369 related articles for article (PubMed ID: 21787228)
1. Long chain omega-3 dietary supplements: a review of the National Library of Medicine Herbal Supplement Database.
Zargar A; Ito MK
Metab Syndr Relat Disord; 2011 Aug; 9(4):255-71. PubMed ID: 21787228
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
3. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
4. A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States.
Kleiner AC; Cladis DP; Santerre CR
J Sci Food Agric; 2015 Apr; 95(6):1260-7. PubMed ID: 25044306
[TBL] [Abstract][Full Text] [Related]
5. Effect of supplementation with calcium salts of fish oil on n-3 fatty acids in milk fat.
Castañeda-Gutiérrez E; de Veth MJ; Lock AL; Dwyer DA; Murphy KD; Bauman DE
J Dairy Sci; 2007 Sep; 90(9):4149-56. PubMed ID: 17699033
[TBL] [Abstract][Full Text] [Related]
6. Assessing the environment for regulatory change for eicosapentaenoic acid and docosahexaenoic acid nutrition labeling.
Brownawell AM; Harris WS; Hibbeln JR; Klurfeld DM; Newton I; Yates A
Nutr Rev; 2009 Jul; 67(7):391-7. PubMed ID: 19566599
[TBL] [Abstract][Full Text] [Related]
7. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
8. Replacement of reduced highly unsaturated fatty acids (HUFA deficiency) in dilative heart failure: dosage of EPA/DHA and variability of adverse peroxides and aldehydes in dietary supplement fish oils.
Rupp TP; Rupp KG; Alter P; Rupp H
Cardiology; 2013; 125(4):223-31. PubMed ID: 23816637
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional study of the combined associations of dietary and supplemental eicosapentaenoic acid + docosahexaenoic acid on Omega-3 Index.
McDonnell SL; French CB; Baggerly CA; Harris WS
Nutr Res; 2019 Nov; 71():43-55. PubMed ID: 31757628
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Omega-3 Fatty Acid Content in Fish Oil Products.
Ward ED; Thomasson K; Fischer KR
J Pharm Pract; 2022 Dec; 35(6):870-873. PubMed ID: 33955300
[TBL] [Abstract][Full Text] [Related]
11. Prescription Omega-3 Fatty Acid Products and Dietary Supplements Are Not Interchangeable.
Hilleman D; Smer A
Manag Care; 2016 Jan; 25(1):46-52. PubMed ID: 26882630
[TBL] [Abstract][Full Text] [Related]
12. Dietary reference intakes for DHA and EPA.
Kris-Etherton PM; Grieger JA; Etherton TD
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):99-104. PubMed ID: 19525100
[TBL] [Abstract][Full Text] [Related]
13. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008.
Papanikolaou Y; Brooks J; Reider C; Fulgoni VL
Nutr J; 2014 Apr; 13():31. PubMed ID: 24694001
[TBL] [Abstract][Full Text] [Related]
14. Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids.
Brunton S; Collins N
Curr Med Res Opin; 2007 May; 23(5):1139-45. PubMed ID: 17519081
[TBL] [Abstract][Full Text] [Related]
15. Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice.
Bhattacharya A; Sun D; Rahman M; Fernandes G
J Nutr Biochem; 2007 Jan; 18(1):23-30. PubMed ID: 16563716
[TBL] [Abstract][Full Text] [Related]
16. ANALYSIS OF ω-3 FATTY ACID CONTENT OF POLISH FISH OIL DRUG AND DIETARY SUPPLEMENTS.
Osadnik K; Jaworska J
Acta Pol Pharm; 2016 Jul; 73(4):875-883. PubMed ID: 29648713
[TBL] [Abstract][Full Text] [Related]
17. Is the world supply of omega-3 fatty acids adequate for optimal human nutrition?
Salem N; Eggersdorfer M
Curr Opin Clin Nutr Metab Care; 2015 Mar; 18(2):147-54. PubMed ID: 25635599
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry.
Salm P; Taylor PJ; Kostner K
Biomed Chromatogr; 2011 Jun; 25(6):652-9. PubMed ID: 20737653
[TBL] [Abstract][Full Text] [Related]
20. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
